Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2025

October 1, 2025 - Non-regulatory press release
Enzymatica to Support Swedish Biathlon Federation as Official Supplier
August 22, 2025 - Regulatory press release
Bulletin from the Extraordinary General Meeting of Enzymatica AB (publ) on 22 August 2025
August 12, 2025 - Regulatory press release
Sana Alajmovic appointed new CEO of Enzymatica AB
August 6, 2025 - Regulatory press release
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
July 17, 2025 - Regulatory press release
Quarterly report Q2/2025: Strong development in Sweden and increased international activity
June 30, 2025 - Non-regulatory press release
Enzymatica’s CFO Therese Filmersson to leave her position
June 26, 2025 - Regulatory press release
Claus Egstrand steps down as CEO of Enzymatica
May 7, 2025 - Regulatory press release
Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025
April 29, 2025 - Regulatory press release
Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion
April 10, 2025 - Regulatory press release
Enzymatica publishes annual report for 2024
April 2, 2025 - Regulatory press release
Notice of Annual General Meeting 2025 in Enzymatica AB (publ)
March 6, 2025 - Non-regulatory press release
Replay Link to Digital Press Briefing – March 5, 2025
February 28, 2025 - Non-regulatory press release
Invitation to Press Briefing – 5 March 2025
February 28, 2025 - Regulatory press release
New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms
February 18, 2025 - Regulatory press release
Year-end report 2024: Strong performance in core markets – preparing for international growth
January 9, 2025 - Non-regulatory press release
Enzymatica focuses on growth with new recruitment – Anna Söderlund joins as Senior Director Marketing & Sales

2024

November 7, 2024 - Regulatory press release
Interim report Q3/2024: Focus on developing existing and new markets
September 12, 2024 - Regulatory press release
Enzymatica announces outcome of new rights issue
September 9, 2024 - Regulatory press release
Enzymatica publishes supplementary prospectus
September 5, 2024 - Regulatory press release
Reported results on secondary endpoints from the University of Kent study on ColdZyme® show significant reduction of symptoms, lost training days and viral load
Load more